Seplat's Q2 Profit Jumped 300%, but 90% of Its 52-Week Run Is Already Priced In

Seplat's Q2 beat looked genuine, with profit and cash flow improving together

Seplat's second quarter stood out for more than the headline beat. Q2 profit before tax reached N561.3 billion, up 302.1% from a year earlier, and the company posted adjusted EPS of $0.21 versus $0.16 expected. Revenue also topped estimates at $1.0 billion versus $955.57 million, while earnings beat forecasts by a wider margin. That usually points to better operating leverage, not just a revenue-side surprise.

The supporting details also improved at the same time. Seplat cited stronger revenue growth, lower cost of sales, better production, a supportive commodity-price backdrop, and lower finance costs. Free cash flow of $526 million in the first half further suggests the profit jump was backed by cash generation.

Operational recovery, balance-sheet repair, and shareholder returns all improved

Production came back where it matters most

The operating recovery lines up with the financials. First-half revenue climbed 30% year on year to $1.8 billion, while revenue rose 30% year-over-year to $1.82 billion. Adjusted EBITDA reached $939 million with a 52% margin, showing that top-line growth was translating into operating profit.

Production recovery is the clearest operational proof. Q2 output rose 15% sequentially after the Q1 pipeline shutdown, and onshore production increased 39% from Q1, adding about 20,000 barrels a day of working-interest output. Seplat was also producing within its 135,000 to 155,000 barrels a day guidance range, which makes the recovery look more like a return to normal operations than a one-off spike.

The balance sheet is cleaner, which changes the flex

Seplat ended the half with net debt reduced by 55% year-to-date to $370.7 million, net leverage improved to 0.25x, and cash at bank at period-end was $433.8 million. That gives the company more room to absorb setbacks and fund planned spending without stressing the balance sheet.

It also matters for capital allocation. Seplat's 2026 capex guidance is $360-440 million, so the improved balance-sheet position supports both investment and shareholder returns at the same time.

Shareholders actually saw the cash

The cash generation was not just staying in the business. Seplat generated free cash flow for H1 was $526 million, with underlying free cash flow before debt at $632 million, and it paid a US$0.12 per share for Q2 2026 dividend. That is a clearer read-through on earnings quality than profit alone.

After a near-doubling, the market is testing durability rather than recovery

Seplat shares finished around $557 after a previous close of $552, leaving the stock near the top of its 52-week range of $238 to $619. In that context, the reaction to the results was more measured than celebratory. The recovery is no longer in dispute; the question is whether there is still enough upside left at this price.

The dividend case still works, but the margin for error is tighter

Investors still have a reason to respect the story. Seplat lifted its full-year payout to $270 million, or $0.45 per share, and added an additional $140 million transaction dividend. That supports the view that cash is reaching shareholders, not just showing up on paper.

But the setup is less forgiving than it was a year ago. Seplat now guides to unit operating cost guidance revised to $14.5-15.5/boe due to Yoho repair costs, which leaves less room for error if production slips or prices soften. The leadership change also shifts from positive surprise to execution watchpoint, with new CEO Effiong Okon takes over August 1 and a new Chairman will assume the role in January.

What has to happen next for the stock to keep making sense?

At this stage, the more useful question is not whether Seplat has improved. It is what the company has to deliver from here for the current valuation to remain justified.

Reasons the setup can still work

• Production holds. Seplat needs only to stay within its 135-155 kboepd 2026 guidance and keep moving toward its 2030 production target adjusted to 170 kboepd net WI post-transaction.
• Cash keeps supporting returns. Investors should watch whether the company continues to back the Planned full-year dividend of $270 million ($0.45/share) plus the additional $140 million transaction dividend.

Reasons to wait for a better entry

• Costs rise without a offsetting payoff. Unit operating cost guidance revised to $14.5-15.5/boe due to Yoho repair costs leaves less cushion if prices weaken.
• The next reports restate the same recovery. After a strong operational recovery, the market likely needs new confirmation, not another version of the same story.

My timing trigger

I would pay full price only on a follow-through quarter: production inside guidance, capex still aligned with the $360-440 million 2026 plan, and dividend support looking durable. Otherwise, waiting for proof or a better entry keeps things simpler.